tirzepatide approval obesity FDA for Zepbound (tirzepatide) injection, the first and only treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Obesity is increasingly addressed with

World Psychiatry 20 , 439441 (2021)

With Hepaglide, you can begin to see noticeable weight loss within 2-4 weeks, with more significant results after 8-12 weeks

But her weight despite being arguably the GOAT of womens tennis remained a talking point, particularly after she gave birth to Olympia

To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)